Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions

Elsevier launches Entellect™ Platform, unlocking value by creating AI-ready life sciences data

 New York, November 14, 2018 – Elsevier, the information analytics business specializing in science and health, today announced the launch of Entellect, a new cloud-based data platform designed to help life sciences companies overcome the challenges of modern R&D by enriching and harmonizing proprietary and external data and delivering it in an AI-ready environment.

 

With nearly a fifth of pharmaceutical spending going to R&D and the average cost of bringing a new drug to market estimated at $4 billion USD, life sciences companies urgently need more efficient ways to analyze data. Drawing on its longstanding experience in the life sciences, Elsevier has created Entellect. This new platform can save time and costs by de-siloing, contextualizing and connecting drug, target, and disease data to deliver normalized, discoverable and model-ready information.

 

“The life sciences are perhaps the most demanding field in which to undertake data science,” said Cameron Ross, Managing Director, Life Science Solutions, Elsevier. “The complexity involved is the reason so many companies are looking to AI, and machine and deep learning, to solve their biggest challenges. Too often their efforts are frustrated because of multiple data management barriers, and they’re not yet seeing the insights from AI they expected.

 

“Entellect provides a sophisticated platform enabling them to get far more value out of their data. We designed Entellect to handle the sorts of data challenges that life sciences companies encounter – from handling huge volumes of existing data stored in individual Electronic Lab Notebooks, to finding the desired piece of information in scientific literature.”

 

Entellect allows researchers to produce far more accurate predictive models across a range of pre- and post-market activities, including drug efficacy studies, risk-benefit analyses and pharmacovigilance activities. Some of the key attributes of Entellect include:

 

·          Alignment and integration with Elsevier’s high-quality data and ontologies

·          Engineered for flexibility and scale – not a “one technology” solution, so building custom applications is easy

·          Incorporates a full-data scientist development stack, so data scientists can work on solving problems not manipulating the data

·          Built on Elsevier’s heritage of rigorous data governance processes, so users can choose what data to trust in their analyses

·          Open platform for collaboration, data and application sharing.

·          Frictionless ingestion of disparate content from multiple sources – such as websites, LIMS, archives, and applications – along with text and data mining of that content

·          Creation of rich knowledgebases of harmonized and linked data through connection of various sources, including Elsevier databases such as Reaxys, Pharmapendium or Embase

 

Entellect is already being used by Elsevier clients to gather, cleanse and connect more than 10,000 different unstructured medical documents in various formats to make them standardized and searchable. Entellect’s taxonomy capabilities allow users to search across various fields including drug names, targets and diseases.

 

“At Elsevier we’ve spent decades creating solutions that allow individual researchers to find answers, and we’ve amassed a wealth of knowledge and practical experience in data science,” said Tim Miller, VP Life Sciences Platform Solutions, Elsevier. “To develop Entellect, we took that data science knowledge and experience and applied it to prepare machine learning solutions.

 

“Entellect has been designed to radically simplify activities like text mining, data normalization, application of ontologies, mapping of ontologies onto multiple data sets – all techniques in which we have extensive experience.”

 

Entellect is a smart and versatile life sciences platform that empowers R&D by leveraging Elsevier’s trusted approach to data integration and harmonization. Entellect delivers connected and AI-ready data by linking and enriching disparate content against established life science taxonomies. Combined with the option of Elsevier data, the result is a scalable and customizable knowledge environment, enabling exploratory and predictive analytics applications.

 

For more information about Entellect, please visit www.elsevier.com/entellect.

Tagged with:

About author

Related Articles